Indian Company Master Data Made Simple
Kilitch Drugs (india) Limited.
Kilitch Drugs (india) Limited. has been active since 1992, providing more than 33 years of industry experience. Kilitch Drugs (india) Limited. is registered with CIN L24239MH1992PLC066718 (reg. no. 66718). This entity is incorporated as company limited by shares. Authorized share capital stands at ₹25.00 crore. Kilitch Drugs (india) Limited.’s paid-up capital stands at ₹16.08 crore.
The company’s main operations are related to manufacture of other chemical products. It is registered in Mumbai. The company is incorporated with the address C 301/2 Midc Ttc Indl Area Pawane, Thane, Thane, Maharashtra, India, 400705. The firm continues to be in active status. Kilitch Drugs (india) Limited. holds the LEI code 335800NMETDAZKVPII87. The firm’s registered email for correspondence is [email protected]. The leadership team includes Sunil Sureshji Jain (CFO).
Profile data last updated: 14/12/2024
Company Overview
- CIN
- Date of Incorporation
- 12/05/1992
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹25,00,00,000.00
- Paid up Capital
- ₹16,08,23,000.00
- Activity
- Manufacture of other chemical products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹2,801.57L | ₹17.24L | ₹6.83L | ₹27.54L |
| Total Liabilities Net Minority Interest | ₹11,232.58L | ₹6,438.83L | ₹6,894.14L | ₹6,955.46L |
| Accumulated Depreciation | -₹2,949.33L | -₹2,739.46L | -₹2,499.60L | -₹2,230.06L |
| Tangible Book Value | ₹18,344.16L | ₹15,646.84L | ₹13,111.28L | ₹11,778.87L |
| Long Term Debt | ₹2,777.04L | ₹0.00L | ₹0.00L | ₹0.00L |
| Goodwill | ₹1,853.60L | ₹1,937.85L | ₹2,022.11L | ₹2,106.36L |
| Long Term Provisions | ₹24.53L | ₹17.24L | ₹6.83L | ₹27.54L |
| Current Debt And Capital Lease Obligation | ₹2,165.36L | ₹3,164.65L | ₹2,219.35L | ₹2,043.18L |
| Total Assets | ₹31,278.38L | ₹24,006.16L | ₹21,952.13L | ₹20,984.82L |
| Machinery Furniture Equipment | ₹5,805.44L | ₹5,316.59L | ₹5,259.06L | ₹4,957.87L |
| Total Equity Gross Minority Interest | ₹20,045.80L | ₹17,567.33L | ₹15,057.99L | ₹14,029.36L |
| Gross PPE | ₹12,231.22L | ₹7,551.50L | ₹7,235.38L | ₹6,870.37L |
| Common Stock | ₹1,608.23L | ₹1,608.23L | ₹1,558.23L | ₹1,558.23L |
| Total Capitalization | ₹23,009.95L | ₹17,629.12L | ₹15,159.72L | ₹13,908.64L |
| Total Debt | ₹4,942.40L | ₹3,164.65L | ₹2,219.35L | ₹2,043.18L |
| Goodwill And Other Intangible Assets | ₹1,888.75L | ₹1,982.28L | ₹2,048.44L | ₹2,129.77L |
| Other Equity Interest | ₹35.43L | ₹35.44L | ₹535.43L | ₹285.43L |
| Capital Stock | ₹1,608.23L | ₹1,608.23L | ₹1,558.23L | ₹1,558.23L |
| Additional Paid In Capital | ₹4,668.38L | ₹4,668.38L | ₹3,832.63L | ₹3,832.63L |
| Total Non Current Assets | ₹13,886.73L | ₹9,406.88L | ₹9,311.82L | ₹9,574.37L |
| Cash Cash Equivalents And Short Term Investments | ₹5,931.39L | ₹6,901.92L | ₹5,912.47L | ₹5,724.35L |
| Invested Capital | ₹25,175.31L | ₹20,793.77L | ₹17,379.07L | ₹15,951.82L |
| Net Tangible Assets | ₹18,344.16L | ₹15,646.84L | ₹13,111.28L | ₹11,778.87L |
| Cash And Cash Equivalents | ₹974.89L | ₹1,891.00L | ₹1,979.40L | ₹1,000.93L |
| Prepaid Assets | ₹820.19L | ₹808.24L | ₹1,051.09L | ₹1,008.88L |
| Stockholders Equity | ₹20,232.91L | ₹17,629.12L | ₹15,159.72L | ₹13,908.64L |
| Other Short Term Investments | ₹4,956.50L | ₹5,010.92L | ₹3,933.07L | ₹4,723.42L |
| Share Issued | ₹164.34L | ₹164.34L | ₹159.23L | ₹159.23L |
| Current Assets | ₹17,391.65L | ₹14,599.28L | ₹12,640.31L | ₹11,410.45L |
| Working Capital | ₹8,960.64L | ₹8,177.69L | ₹5,753.00L | ₹4,482.53L |
| Net Debt | ₹3,967.51L | ₹1,273.65L | ₹239.95L | ₹1,042.25L |
| Ordinary Shares Number | ₹164.34L | ₹164.34L | ₹159.23L | ₹159.23L |
| Current Debt | ₹2,165.36L | ₹3,164.65L | ₹2,219.35L | ₹2,043.18L |
| Long Term Debt And Capital Lease Obligation | ₹2,777.04L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Liabilities | ₹8,431.01L | ₹6,421.59L | ₹6,887.31L | ₹6,927.92L |
| Retained Earnings | ₹11,093.33L | ₹8,423.27L | ₹6,963.13L | ₹5,918.32L |
| Net PPE | ₹9,281.89L | ₹4,812.04L | ₹4,735.78L | ₹4,640.31L |
| Construction In Progress | ₹4,729.45L | ₹596.50L | ₹361.92L | ₹316.11L |
| Common Stock Equity | ₹20,232.91L | ₹17,629.12L | ₹15,159.72L | ₹13,908.64L |
| Other Non Current Assets | -₹0.02L | -₹0.02L | ₹0.02L | -₹1.97L |
| Other Intangible Assets | ₹35.15L | ₹44.43L | ₹26.33L | ₹23.41L |
| Inventory | ₹2,157.83L | ₹558.18L | ₹240.70L | ₹528.82L |
| Other Properties | ₹411.29L | ₹370.34L | ₹352.85L | ₹340.82L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Changes In Cash | -₹916.13L | -₹88.45L | ₹978.45L | -₹243.91L |
| Financing Cash Flow | ₹1,324.33L | ₹880.67L | -₹71.63L | ₹702.83L |
| Free Cash Flow | -₹2,933.11L | -₹798.54L | -₹122.61L | -₹241.88L |
| Investing Cash Flow | -₹3,994.69L | -₹815.62L | ₹791.50L | -₹1,525.04L |
| End Cash Position | ₹980.05L | ₹1,896.18L | ₹1,984.60L | ₹1,006.15L |
| Capital Expenditure | -₹4,687.34L | -₹645.04L | -₹381.19L | -₹820.18L |
| Beginning Cash Position | ₹1,896.18L | ₹1,984.60L | ₹1,006.15L | ₹1,250.05L |
| Issuance Of Capital Stock | ₹0.00L | ₹385.75L | ₹250.00L | ₹258.78L |
| Operating Cash Flow | ₹1,754.23L | -₹153.50L | ₹258.58L | ₹578.30L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Rent Expense Supplemental | ₹111.80L | ₹139.15L | ₹37.73L | ₹48.76L |
| Net Income From Continuing Operation Net Minority Interest | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L | ₹736.72L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹4,262.57L | ₹2,863.35L | ₹2,048.38L | ₹1,327.84L |
| Operating Revenue | ₹19,723.98L | ₹15,360.62L | ₹13,885.82L | ₹11,295.84L |
| Total Unusual Items | ₹395.99L | ₹138.85L | ₹81.82L | ₹90.19L |
| Total Expenses | ₹16,860.57L | ₹13,252.29L | ₹12,450.75L | ₹10,319.55L |
| Tax Effect Of Unusual Items | ₹109.51L | ₹41.46L | ₹25.41L | ₹31.90L |
| Total Unusual Items Excluding Goodwill | ₹395.99L | ₹138.85L | ₹81.82L | ₹90.19L |
| Interest Income Non Operating | ₹359.45L | ₹40.79L | ₹30.17L | ₹21.91L |
| Interest Expense Non Operating | ₹504.13L | ₹592.94L | ₹491.89L | ₹119.84L |
| Interest Income | ₹359.45L | ₹40.79L | ₹30.17L | ₹21.91L |
| General And Administrative Expense | ₹301.92L | ₹375.91L | ₹199.01L | ₹195.17L |
| Net Income From Continuing And Discontinued Operation | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L | ₹736.72L |
| Reconciled Depreciation | ₹311.02L | ₹334.96L | ₹355.06L | ₹246.56L |
| Net Income Continuous Operations | ₹2,494.01L | ₹1,357.52L | ₹828.27L | ₹621.37L |
| Reconciled Cost Of Revenue | ₹10,675.26L | ₹8,046.80L | ₹7,713.48L | ₹6,825.33L |
| Operating Income | ₹2,863.41L | ₹2,108.33L | ₹1,435.07L | ₹976.29L |
| Net Income | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L | ₹736.72L |
| Diluted Average Shares | ₹164.34L | ₹162.78L | ₹159.23L | ₹159.06L |
| Selling And Marketing Expense | ₹194.22L | ₹111.38L | ₹65.95L | ₹73.10L |
| Total Other Finance Cost | ₹27.89L | ₹10.70L | ₹16.40L | ₹13.26L |
| Normalized Income | ₹2,670.06L | ₹1,362.75L | ₹988.40L | ₹678.43L |
| Net Non Operating Interest Income Expense | -₹172.57L | -₹562.85L | -₹478.12L | -₹111.19L |
| Gross Profit | ₹9,048.72L | ₹7,313.82L | ₹6,172.34L | ₹4,470.51L |
| EBIT | ₹3,951.55L | ₹2,528.39L | ₹1,693.32L | ₹1,081.28L |
| Diluted NIAvailto Com Stockholders | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L | ₹736.72L |
| Cost Of Revenue | ₹10,675.26L | ₹8,046.80L | ₹7,713.48L | ₹6,825.33L |
| Net Interest Income | -₹172.57L | -₹562.85L | -₹478.12L | -₹111.19L |
| Normalized EBITDA | ₹3,866.58L | ₹2,724.50L | ₹1,966.56L | ₹1,237.65L |
| Operating Expense | ₹6,185.31L | ₹5,205.49L | ₹4,737.27L | ₹3,494.22L |
| Net Income Common Stockholders | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L | ₹736.72L |
| Pretax Income | ₹3,447.42L | ₹1,935.45L | ₹1,201.43L | ₹961.44L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹496.14L | ₹487.29L | ₹264.96L | ₹268.27L |
| Total Revenue | ₹19,723.98L | ₹15,360.62L | ₹13,885.82L | ₹11,295.84L |
| Other Operating Expenses | ₹3,887.60L | ₹3,014.76L | ₹2,741.49L | ₹2,137.62L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹504.13L | ₹592.94L | ₹491.89L | ₹119.84L |
| Basic Average Shares | ₹164.34L | ₹162.78L | ₹159.23L | ₹159.06L |
| Tax Provision | ₹953.41L | ₹577.93L | ₹373.16L | ₹340.07L |
| Net Income Including Noncontrolling Interests | ₹2,494.01L | ₹1,357.52L | ₹828.27L | ₹621.37L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 12/05/1992 | Mukund Prataprai Mehta | 00147876 | Managing Director | View other directorships |
| 29/09/2007 | Bhavin Mukund Mehta | 00147895 | Whole-time director | View other directorships |
| 30/09/2014 | Mira Bhavin Mehta | 01902831 | Managing Director | View other directorships |
| 01/04/2015 | Hemang Jagadish Engineer | 02317989 | Director | View other directorships |
| 16/03/2018 | Vasudev Krishnamurti | 00567672 | Director | View other directorships |
| 28/06/2018 | Venkita Subramanian Rajan | 00059146 | Director | View other directorships |
| 01/03/2021 | Sunil Sureshji Jain | *****8872E | CFO | |
| 05/05/2022 | Pushpa Nyoupane | *****8988L | Company Secretary | |
| 27/08/2024 | Dipen Jayantilal Jain | 01148262 | Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 11/12/2024 | Form AOC-4(XBRL)-11122024-signed | - |
| 25/11/2024 | Form MGT-7-25112024_signed | - |
| 17/02/2024 | Form Addendum to AOC-4 CSR-17022024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
C 301/2 Midc Ttc Indl Area Pawane, Thane, Thane, Maharashtra, India, 400705
FAQ
What is the incorporation date of Kilitch Drugs (india) Limited.?
The incorporation date of Kilitch Drugs (india) Limited. is 12/05/1992.
Who are the current board members & directors of Kilitch Drugs (india) Limited.?
The current board member of Kilitch Drugs (india) Limited. are:
- Vasudev Krishnamurti
- Vasudev Krishnamurti
- Mukund Prataprai Mehta
- Bhavin Mukund Mehta
- Venkita Subramanian Rajan
- Mira Bhavin Mehta
- Hemang Jagadish Engineer
- Dipen Jayantilal Jain
What is the registered address of Kilitch Drugs (india) Limited.?
The registered address of Kilitch Drugs (india) Limited. is C 301/2 Midc Ttc Indl Area Pawane, Thane, Thane, Maharashtra, India, 400705.
What is the Corporate Identification Number of Kilitch Drugs (india) Limited.?
The Corporate Identification Number of Kilitch Drugs (india) Limited. is L24239MH1992PLC066718.